Nexium Buyers Point To Dow Ruling To Support Class Cert.
By Allissa Wickham ( October 3, 2014, 3:36 PM EDT) -- Plaintiffs fighting AstraZeneca PLC and other drug producers' attempt to nix their class certification in a suit over alleged pay-for-delay deals regarding the acid reflux medication Nexium sought to bolster their case Thursday by pointing the First Circuit to a recent ruling upholding certification for polyurethane purchasers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.